BRATISLAVA, October 20 (IPS) – When Tsholofelo Msimango joined a small trial of a new drug regimen for tuberculosis (TB) treatment a decade ago, she had no idea whether the medicines she was about to be given would help her.

Read the full story, “XDR-TB Drug Trial Participants Continue to Celebrate its Success”, on globalissues.org